#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3688	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2548	431.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1683	1683	C	561	C	491	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5822	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3930	443.8	0	.	n	.	0	C84T	SNP	84	84	C	641	641	T	617	T,C	400,130	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5822	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3930	443.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2528	2528	C	520	C,T	340,108	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5822	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3930	443.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2602	2602	A	537	A,T	464,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5822	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3930	443.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3154	3154	C	537	C	463	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	550	folP	852	852	100.0	folP.l6.c17.ctg.1	1911	86.5	1	SNP	p	R228S	0	.	.	682	684	CGC	1238	1240	CGC	149;149;149	C;G;C	124;128;126	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1328	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3680	108.3	1	SNP	p	S91F	0	.	.	271	273	TCC	724	726	TCC	116;118;118	T;C,A;C	100;100,1;101	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1328	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3680	108.3	1	SNP	p	D95G	0	.	.	283	285	GAC	736	738	GAC	118;117;117	G;A;C	101;97;98	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1328	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3680	108.3	1	SNP	p	D95N	0	.	.	283	285	GAC	736	738	GAC	118;117;117	G;A;C	101;97;98	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	27	466	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1647	85.0	1	SNP	p	G45D	0	.	.	133	135	GGC	648	650	GGC	147;146;145	G;G;C	129;131;129	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	346	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1290	80.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	1222	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3099	117.8	1	SNP	p	D86N	0	.	.	256	258	GAC	647	649	GAC	151;151;151	G;A;C	127;125;125	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	1222	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3099	117.8	1	SNP	p	S87W	0	.	.	259	261	AGT	650	652	AGT	150;150;150	A;G;T	123;123;128	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	1222	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3099	117.8	1	SNP	p	S87R	0	.	.	259	261	AGT	650	652	AGT	150;150;150	A;G;T	123;123;128	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	1222	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3099	117.8	1	SNP	p	S87I	0	.	.	259	261	AGT	650	652	AGT	150;150;150	A;G;T	123;123;128	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	1222	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3099	117.8	1	SNP	p	S88P	0	.	.	262	264	TCC	653	655	TCC	149;150;149	T;C;C	124;124;128	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1004	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2966	101.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1710	1712	GGC	125;125;123	G;G;C	112;112;111	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1333	1335	GCA	130;130;129	G,A;C;A	105,1;107;111	penA.15.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1336	1338	ATC	130;130;130	A,C;T,C;C	109,1;106,1;111	penA.15.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1348	1350	GTG	131;131;131	G;T;G	113;109;114	penA.15.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1348	1350	GTG	131;131;131	G;T;G	113;109;114	penA.15.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1849	1851	ACC	105;106;107	A,G;C;C	93,1;93;95	penA.15.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1903	1905	GCG	108;107;106	G;C;G	96;87;89	penA.15.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1903	1905	GCG	108;107;106	G;C;G	96;87;89	penA.15.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	G542S	0	.	.	1624	1626	GGC	2026	2028	GGC	113;113;112	G,C;G;C	96,1;101;98	penA.15.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2035	2037	GGC	112;111;111	G,C;G;C,T	97,1;96;97,1	penA.15.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	27	872	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2683	97.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2053	2055	CCG	114;114;115	C;C;G,C	90;96;95,1	penA.15.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1184	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3240	108.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1690	1692	CTG	117;118;117	C;T;G	102;103;106	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	614	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2156	85.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	732	732	C	109	C	92	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	27	624	porB1a	984	984	100.0	porB1a.l6.c17.ctg.1	1641	111.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2192	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5127	128.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2142	2144	CAT	114;115;114	C;A;T,G	102;101;99,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	342	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1287	79.8	1	SNP	p	V57M	0	.	.	169	171	GTG	657	659	GTG	146;145;148	G;T;G	124;122;123	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
